American Oriental Bioengineering Other Current Liabilities

American Oriental Bioengineering (AOBI) currently reports a other current liabilities of $19M as of September 2013. That compares with $23M in the prior-year period — down 18.5% year over year. Use the charts on this page to explore American Oriental Bioengineering's other current liabilities history and peer comparisons.

American Oriental Bioengineering's other current liabilities decreased from $23M to $19M — a 18.5% year-over-year decrease (period ending September 2013). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

American Oriental Bioengineering reported $19M in other current liabilities as of September 2013. That compares with $23M in the prior-year period — down 18.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for American Oriental Bioengineering, and consider following AOBI for alerts when major investors trade the stock.

American Oriental Bioengineering is classified in the Healthcare sector. On other current liabilities, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AOBI with unrelated industries.